Juniper Pharma Services strengthens capsule capability with Xcelodose

2 years ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage capsule filling expertise with the expansion of its Xcelodose® powder micro-dosing system as part of its suite of GMP capabilities. The move by the contract development and manufacturing organisation (CDMO) follows demand from its clients to

Demonstrating Therapeutic Equivalence for Generic Topical Products

2 years ago

Our Chief Technical Officer, Rob Harris discusses how the determination of topical bioequivalence requires a multi-faceted approach, tailored specifically to the generic-drug formulation in this article as featured in Pharmaceutical Technology entitled ‘Demonstrating Therapeutic Equivalence for Generic Topical Products’. You can read full article online via PharmTech.com.